Hwail Pharmaceutical Company Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hwail Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
CKD Bio Corp
sales of 106.69 billion Korean Won [US$90.79 million]
of which 100%
was Pharmaceutical Manufacturing),
Ctc Bio, Incorporation.
(118.99 billion Korean Won [US$101.26 million]
Kolon Life Science Incorporation
(121.18 billion Korean Won [US$103.12 million]
of which 42%
was Pharmaceutical Business).
Hwail Pharmaceutical Company Limited reported sales of 106.13 billion Korean Won (US$90.32 million)
December of 2015.
increase of 10.4%
versus 2014, when the company's sales were 96.10 billion Korean Won.
Sales at Hwail Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 40%).